Qwoted is a free expert network: we help reporters connect with experts & we help those same experts build relationships with top reporters.
Event Date |
Mon Sep 11 BST - Wed Sep 13 BST (over 7 years ago)
In your timezone (EST): Mon Sep 11 12:00am - Wed Sep 13 12:00am |
Location |
Hilton London Olympia
380 Kensington High Street London W14 8NL United Kingdom |
Region | EMEA |
“The Global Cell And Gene Therapy Market Is Estimated To Be Worth Between £9 to £14 Billion Per Year By 2025”
The race towards commercialisation of cell and gene products has already begun. Where technology innovations are pathing the way towards the development of these products, challenges surrounding scale up and closed system processing highlight areas that need our focus so that cell and gene therapy products can be produced on an industrial scale
David Sourdive
Executive Vice President Technical Operations
Cellectis
Anne Dickinson
Head Tyneside Leukaemia Research Laboratories
Newcastle Cellular Therapies Facility
Magda Papadaki
Head of Manufacturing Innovation
ABPI
Alex Bloom
Director Global Regulatory Affairs
Cell Medica
Stefan Krahulec
Technology and Inovation Manager
Boehringer Ingelheim
Donna McLaren
Process Science Manager – CMC
ReNeuron
Dieter Hauwart
VP Operations
Celyad
Christine Muellar
Science Associate
Eufets
Janet Downie
Chief Executive Officer
Roslin Cell Therapies
Dr. Houria Bachtarzi
Regulatory Affairs Specialist Consultant in Gene and Cell Therapies
ERA
Nina Kotsopoulou
Director Process Development
Autolus
Peter Wernet
CEO
RheinCell Therapeutics GmbH
Sarah Goulding
Knowledge Transfer Manager
Innovate UK
Stefano Baila
Process Development Manager
Celyad
Sarah Snykers
QC Manager
Celyad
Stéphan Reynier
Chief Regulatory & Compliance Officer
Cellectis
Chris Fisher
Head of Advanced Therapy Production
Guy's and St Thomas' NHS Foundation Trust and KCL Clinical Research Facility
Catapult
Macopharma
PBS Biotech